治疗及医学验光配镜等眼科医疗服务

Search documents
爱尔眼科10月16日获融资买入8027.37万元,融资余额23.63亿元
Xin Lang Cai Jing· 2025-10-17 01:30
Core Viewpoint - Aier Eye Hospital experienced a decline of 1.26% in stock price on October 16, with a trading volume of 708 million yuan, indicating a potential shift in investor sentiment and market dynamics [1] Financing Summary - On October 16, Aier Eye Hospital had a financing buy-in amount of 80.27 million yuan and a financing repayment of 51.12 million yuan, resulting in a net financing buy of 29.16 million yuan [1] - The total financing and securities balance for Aier Eye Hospital reached 2.376 billion yuan, with the financing balance accounting for 2.04% of the circulating market value, which is below the 30th percentile level over the past year, indicating a low financing level [1] - In terms of securities lending, Aier Eye Hospital repaid 3,300 shares and sold 66,900 shares on October 16, with a selling amount of 837,600 yuan, while the remaining securities lending volume was 1.0411 million shares, with a balance of 13.03 million yuan, exceeding the 90th percentile level over the past year, indicating a high lending level [1] Business Performance - As of June 30, Aier Eye Hospital reported a total of 343,900 shareholders, a decrease of 1.00% from the previous period, with an average of 23,064 circulating shares per person, an increase of 1.01% [2] - For the first half of 2025, Aier Eye Hospital achieved an operating income of 11.507 billion yuan, representing a year-on-year growth of 9.12%, and a net profit attributable to shareholders of 2.051 billion yuan, with a slight year-on-year increase of 0.05% [2] Dividend and Shareholding Summary - Aier Eye Hospital has cumulatively distributed dividends of 7.12 billion yuan since its A-share listing, with 3.6 billion yuan distributed over the past three years [3] - As of June 30, 2025, the top ten circulating shareholders included Hong Kong Central Clearing Limited as the third-largest shareholder with 193 million shares, a decrease of 17.9976 million shares from the previous period [3] - Other notable shareholders include Huabao CSI Medical ETF and E Fund Growth Enterprise Board ETF, with varying changes in their holdings compared to the previous period [3]